Identification of residual inflammatory cardiovascular risk.

25 August 2018 (15:48 - 16:03)

Organised by:

Video

Sign in to view the resources

Slides

About the speaker

Professor Jan H Cornel

Radboudumc, Nijmegen (Netherlands (The))

5 More presentations in this session

Presentation thumbnail

Welcome and Introduction - Emerging evidence-based approaches to reduce residual atherosclerotic risk.

Professor W. Koenig (Munich, DE)

Presentation thumbnail

Inflammation in atherosclerosis: time for translation?

Professor P. Libby (Boston, US)

Presentation thumbnail

Therapeutic strategies for secondary cardiovascular disease prevention.

Doctor P. Ridker (Boston, US)

Presentation thumbnail

Audience Q&A and panel discussion.

Professor P. Libby (Boston, US) Professor W. Koenig (Munich, DE) Professor J. Cornel (Nijmegen, NL) Doctor P. Ridker (Boston, US)

Presentation thumbnail

Learning points and close - Emerging evidence-based approaches to reduce residual atherosclerotic risk.

Professor W. Koenig (Munich, DE)

Access the full session

Session thumbnail

Emerging evidence-based approaches to reduce residual atherosclerotic risk

The Event

ESC Congress 2018

25 August 2018 15:48 CET

You may be interested in

Congress Session

Inflammation in atherosclerotic cardiovascular disease (ASCVD): the spark before the fire?

27 August 2022

Congress Presentation

Inflammatory risk in patients with coronary artery disease: the impact of cardiac rehabilitation and association to cardiorespiratory fitness

23 April 2026

Webinar

How to address residual cardiovascular risk

28 March 2022

Webinar

Quantification of coronary inflammation using coronary CT angiography to improve patient risk prediction and stratification

27 September 2021

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources